Novavax is a global clinical-stage biopharmaceutical company engaged in creating novel vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates with the goal of enabling countries to be well-prepared for and more effectively responsive to rapidly spreading infections. Committed to using its technology platforms to create location-specific vaccine solutions, Novavax is involved in a number of international partnerships. For more information, visit the company’s Web site at www.novavax.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: